(VIANEWS) – SCYNEXIS (SCYX), Equus Total Return (EQS), Halozyme Therapeutics (HALO) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SCYNEXIS (SCYX)
285.2% sales growth and 64.05% return on equity
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections; and ibrexafungerp that has completed Phase 3 CANDLE study for the prevention of recurrent (VVC). It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
Earnings Per Share
As for profitability, SCYNEXIS has a trailing twelve months EPS of $0.85.
PE Ratio
SCYNEXIS has a trailing twelve months price to earnings ratio of 2.21. Meaning, the purchaser of the share is investing $2.21 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 64.05%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 75.8% and 62.2%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9836.1%, now sitting on 135.66M for the twelve trailing months.
2. Equus Total Return (EQS)
139.2% sales growth and 7.5% return on equity
Equus Total Return, Inc. is a business development company (BDC) specializing in leveraged buyouts, management buyouts, corporate partnerships/joint ventures, growth and expansion capital, acquisition financing, roll-up acquisition strategies, operational turnarounds, recapitalizations of existing businesses, special situations, equity and equity-oriented securities issued by privately owned companies, debt securities including subordinate debt, debt convertible into common or preferred stock, or debt combined with warrants and common and preferred stock, and preferred equity financing. It invests in small to mid-sized companies and acts as a lead investor. It invests in technology, telecommunication, financial services, natural resource and industrial manufacturing and services. It invests in companies engaged in the alternative energy, real estate, healthcare, education, e-learning, leisure and entertainment, and foreign investment sector in the United States, China, India, and Europe. It investments include common and preferred stock, debt convertible into common or preferred stock, debt combined with warrants and options, and other rights to acquire common or preferred stock. It seeks to invest in companies between $1 million to $25 million with revenues between $5 million and $150 million with EBITDA between $2 million to $50 million. It seeks to take control and non-control equity positions. Equus Total Return, Inc. was founded in 1991 and is based in Houston, Texas with additional office in Vancouver, Canada.
Earnings Per Share
As for profitability, Equus Total Return has a trailing twelve months EPS of $0.22.
PE Ratio
Equus Total Return has a trailing twelve months price to earnings ratio of 6.73. Meaning, the purchaser of the share is investing $6.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.5%.
Yearly Top and Bottom Value
Equus Total Return’s stock is valued at $1.48 at 14:22 EST, way under its 52-week high of $1.75 and way above its 52-week low of $1.32.
Sales Growth
Equus Total Return’s sales growth is 139.2% for the present quarter and 139.2% for the next.
3. Halozyme Therapeutics (HALO)
26.3% sales growth and 105.22% return on equity
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. Its flagship product is Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in subcutaneous urography and to improve resorption of radiopaque agents. The company also develops Perjeta; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; Centre for the AIDS Programme of Research in South Africa; and ViiV Healthcare Limited for small and large molecule targets for the treatment and prevention of HIV. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.
Earnings Per Share
As for profitability, Halozyme Therapeutics has a trailing twelve months EPS of $1.7.
PE Ratio
Halozyme Therapeutics has a trailing twelve months price to earnings ratio of 20.15. Meaning, the purchaser of the share is investing $20.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 105.22%.
4. ServiceNow (NOW)
22.9% sales growth and 27.1% return on equity
ServiceNow, Inc. provides enterprise cloud computing solutions that defines, structures, consolidates, manages, and automates services for enterprises worldwide. The company operates the Now platform for workflow automation, artificial intelligence, machine learning, robotic process automation, process mining, performance analytics, electronic service catalogs and portals, configuration management systems, data benchmarking, encryption, and collaboration and development tools. It also provides information technology (IT) service management applications; IT service management product suite for enterprise's employees, customers, and partners; strategic portfolio management product suite; IT operations management product that connects a customer's physical and cloud-based IT infrastructure; IT asset management; and security operations that connects with internal and third party. In addition, the company offers integrated risk management product to manage risk and resilience; environmental, social and governance management product; human resources, legal, and workplace service delivery products; safe workplace suite products; customer service management product; and field service management applications. Further, it provides App Engine product; Automation Engine enables application to extend workflows; platform privacy and security product; procurement operations management suite; and professional and customer support services. The company serves government, financial services, healthcare, telecommunications, manufacturing, IT services, technology, oil and gas, education, and consumer products through direct sales team and resale partners. It has a strategic partnership with Celonis to help customers identify and prioritize processes that are suitable for automation. The company was formerly known as Service-now.com and changed its name to ServiceNow, Inc. in May 2012. The company was founded in 2004 and is headquartered in Santa Clara, California.
Earnings Per Share
As for profitability, ServiceNow has a trailing twelve months EPS of $7.72.
PE Ratio
ServiceNow has a trailing twelve months price to earnings ratio of 84.6. Meaning, the purchaser of the share is investing $84.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.1%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ServiceNow’s EBITDA is 15.15.
Yearly Top and Bottom Value
ServiceNow’s stock is valued at $653.13 at 14:22 EST, above its 52-week high of $636.43.
Sales Growth
ServiceNow’s sales growth is 24% for the present quarter and 22.9% for the next.
Volume
Today’s last reported volume for ServiceNow is 517297 which is 53.75% below its average volume of 1118540.
Previous days news about ServiceNow(NOW)
- According to Zacks on Monday, 13 November, "SentinelOne is gaining from its expanding partner base that includes the likes of Chubb (CB Quick QuoteCB – Free Report) , ServiceNow (NOW Quick QuoteNOW – Free Report) , Mandiant and Amazon (AMZN Quick QuoteAMZN – Free Report) cloud arm, Amazon Web Services ("AWS"), which leverages the Singularity XDR platform to provide end-to-end threat detection and automated response.", "The SentinelOne App seamlessly syncs threats into ServiceNow Incident Response for security operations and incident response."
5. FirstCash (FCFS)
12% sales growth and 12.35% return on equity
FirstCash Holdings, Inc, together with its subsidiaries, operates retail pawn stores in the United States, Mexico, and rest of Latin America. Its pawn stores lend money on the collateral of pledged personal property, including jewelry, electronics, tools, appliances, sporting goods, and musical instruments; and retails merchandise acquired through collateral forfeitures on forfeited pawn loans and over-the-counter purchases of merchandise directly from customers. The company is also involved in melting scrap jewelry, as well as sells gold, silver, and diamonds in commodity markets. As of December 31, 2021, it operated 1,081 stores in the United States and the District of Columbia; 1,656 stores in Mexico; 60 stores in Guatemala; 13 stores in El Salvador; and 15 stores in Colombia. The company was incorporated in 1988 and is headquartered in Fort Worth, Texas.
Earnings Per Share
As for profitability, FirstCash has a trailing twelve months EPS of $4.99.
PE Ratio
FirstCash has a trailing twelve months price to earnings ratio of 21.92. Meaning, the purchaser of the share is investing $21.92 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.35%.
Moving Average
FirstCash’s value is way above its 50-day moving average of $97.86 and way higher than its 200-day moving average of $95.45.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 6.2% and 7.9%, respectively.
Previous days news about FirstCash(FCFS)
- Has firstcash (fcfs) outpaced other business services stocks this year?. According to Zacks on Wednesday, 15 November, "Looking more specifically, FirstCash Holdings belongs to the Financial Transaction Services industry, which includes 38 individual stocks and currently sits at #160 in the Zacks Industry Rank. "
6. CNA Financial Corporation (CNA)
10.6% sales growth and 15.48% return on equity
CNA Financial Corporation provides commercial property and casualty insurance products primarily in the United States. It operates through Specialty, Commercial, International, Life & Group, and Corporate & Other segments. The company offers professional liability coverages and risk management services to various professional firms, including architects, real estate agents, and accounting and law firms; directors and officers, employment practices, fiduciary, and fidelity coverages to small and mid-size firms, public and privately held firms, and not-for-profit organizations; professional and general liability, as well as associated standard property and casualty coverages for healthcare industry; surety and fidelity bonds; and warranty and alternative risks products. It also provides property insurance products, such as property, marine, boiler, and machinery coverages; casualty insurance products comprising workers' compensation, general and product liability, commercial auto, and umbrella coverages; specialized loss-sensitive insurance programs and total risk management services; and run-off long term care policies. In addition, the company offers long-tail exposures comprising commercial automobile liability, workers compensation, general and medical professional liability, other professional and management liability, and assumed reinsurance run-off and products liability; and short-tail exposures, such as property, commercial automobile physical damage, marine, surety, and warranty. It markets its products through independent agents, brokers, and general underwriters to small, medium, and large businesses; insurance companies; associations; professionals; and other groups in the marine, oil and gas, construction, manufacturing, life science, property, financial services, healthcare, and technology industries. The company was founded in 1853 and is headquartered in Chicago, Illinois. CNA Financial Corporation operates as a subsidiary of Loews Corporation.
Earnings Per Share
As for profitability, CNA Financial Corporation has a trailing twelve months EPS of $4.73.
PE Ratio
CNA Financial Corporation has a trailing twelve months price to earnings ratio of 8.26. Meaning, the purchaser of the share is investing $8.26 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.48%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.8%, now sitting on 12.9B for the twelve trailing months.
Volume
Today’s last reported volume for CNA Financial Corporation is 98071 which is 25.91% below its average volume of 132384.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Nov 9, 2023, the estimated forward annual dividend rate is 1.68 and the estimated forward annual dividend yield is 4.3%.
Yearly Top and Bottom Value
CNA Financial Corporation’s stock is valued at $39.09 at 14:22 EST, way under its 52-week high of $45.42 and higher than its 52-week low of $36.17.
7. RCI Hospitality Holdings (RICK)
10.4% sales growth and 14.64% return on equity
RCI Hospitality Holdings, Inc., through its subsidiaries, engages in the hospitality and related businesses in the United States. The company operates through Nightclubs, Bombshells, and Other segments. It owns and/or operates upscale adult nightclubs serving primarily businessmen and professionals under the Rick's Cabaret, Jaguars Club, Tootsie's Cabaret, XTC Cabaret, Club Onyx, Hoops Cabaret and Sports Bar, Scarlett's Cabaret, Temptations Adult Cabaret, Foxy's Cabaret, Vivid Cabaret, Downtown Cabaret, Cabaret East, The Seville, Silver City Cabaret, and Kappa Men's Club. The company also operates restaurants and sports bars under the Bombshells Restaurant & Bar brand, as well as a dance club under the Studio 80 brand. In addition, it owns two national industry trade publications serving the adult nightclubs industry and the adult retail products industry; a national industry convention and tradeshow; and two national industry award shows, as well as approximately a dozen industry and social media Websites. Further, RCI Hospitality Holdings, Inc. holds license to sell Robust Energy Drink in the United States. The company was formerly known as Rick's Cabaret International, Inc. and changed its name to RCI Hospitality Holdings, Inc. in August 2014. RCI Hospitality Holdings, Inc. was founded in 1983 and is based in Houston, Texas.
Earnings Per Share
As for profitability, RCI Hospitality Holdings has a trailing twelve months EPS of $4.06.
PE Ratio
RCI Hospitality Holdings has a trailing twelve months price to earnings ratio of 13.9. Meaning, the purchaser of the share is investing $13.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.64%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
RCI Hospitality Holdings’s EBITDA is 49.84.
8. DXP Enterprises (DXPE)
5.1% sales growth and 15.49% return on equity
DXP Enterprises, Inc., together with its subsidiaries, engages in distributing maintenance, repair, and operating (MRO) products, equipment, and services to the energy and industrial customers primarily in the United States and Canada. It operates through three segments: Service Centers (SC), Supply Chain Services (SCS), and Innovative Pumping Solutions (IPS). The SC segment offers MRO products, equipment, and integrated services, including technical expertise and logistics services. It offers a range of MRO products in the rotating equipment, bearing, power transmission, hose, fluid power, metal working, fastener, industrial supply, safety products, and safety services categories. This segment serves customers in the oil and gas, food and beverage, petrochemical, transportation, other general industrial, mining, construction, chemical, municipal, agriculture, and pulp and paper industries. The SCS segment manages procurement and inventory management solutions; and offers outsourced MRO solutions for sourcing MRO products, including inventory optimization and management, store room management, transaction consolidation and control, vendor oversight and procurement cost optimization, productivity improvement, and customized reporting services. Its programs include SmartAgreement, a procurement solution for various MRO categories; SmartBuy, an on-site or centralized MRO procurement solution; SmartSource, an on-site procurement and storeroom management solution; SmartStore, an e-Catalog solution; SmartVend, an industrial dispensing solution; and SmartServ, an integrated service pump solution. The IPS segment fabricates and assembles custom-made pump packages, remanufactures pumps, and manufactures branded private label pumps. The company was founded in 1908 and is based in Houston, Texas.
Earnings Per Share
As for profitability, DXP Enterprises has a trailing twelve months EPS of $3.09.
PE Ratio
DXP Enterprises has a trailing twelve months price to earnings ratio of 10.56. Meaning, the purchaser of the share is investing $10.56 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.49%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 28% and 148.6%, respectively.
Moving Average
DXP Enterprises’s value is under its 50-day moving average of $34.58 and higher than its 200-day moving average of $32.06.
Yearly Top and Bottom Value
DXP Enterprises’s stock is valued at $32.63 at 14:22 EST, way below its 52-week high of $39.89 and way above its 52-week low of $22.06.
